Current role
Birgit Schultes, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Birgit Schultes, Ph.D.
Intellia Therapeutics, Inc. reported in an 8-K filed January 10, 2025 that Birgit Schultes, Ph.D. was appointed Executive Vice President and Chief Scientific Officer, effective January 13, 2025.
“Birgit Schultes, Ph.D. will become the Company's Executive Vice President and CSO, effective as of January 13, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-01-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Intellia Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Edward J. Dulac III CFO
- Andrew D. Schiermeier COO
- James Basta General Counsel
- Michael P. Dube Chief Accounting Officer
- Bill Chase Board Member
- Brian Goff Board Member
- Georgia Keresty Board Member
- Georgia Keresty, Ph.D., M.P.H. Board Member
- John M. Leonard Board Member
- John M. Leonard, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.